RPS7P2: A Drug Target / Disease Biomarker (G100270868)

Target Name: RPS7P2

NCBI ID: G100270868

RPS7P2

Other Name(s): ribosomal protein S7 pseudogene 2 | RPS7_1_102 | Ribosomal protein S7 pseudogene 2

RPS7P2: A Drug Target / Disease Biomarker

RNA-protein interactions are a crucial aspect of gene regulation, and the protein encoded by the RPS7P2 gene is one of the most well-studied RNA-protein interactions in the cell. RPS7P2 is a RNA-protein complex that plays a role in regulating gene expression and has been identified as a potential drug target in the field of neurodegenerative diseases.

The RPS7P2 gene encodes a protein that contains 76% protein and 30% RNA components. The protein is composed of two distinct domains: a N-terminal domain that contains a conserved nucleotide sequence and a C-terminal domain that contains a conserved secondary structure. The N-terminal domain is responsible for the protein's stability and functions as a scaffold, while the C-terminal domain is involved in the protein's interactions with other proteins and factors.

RPS7P2 has been shown to play a role in various cellular processes, including cell division, cell signaling, and neurodegenerative diseases. One of the most well-studied functions of RPS7P2 is its role in the regulation of neurotransmitter release from dopamine-producing neurons. RPS7P2 has been shown to interact with the neurotransmitter transporter, dopamine, and modulate its activity.

In addition to its role in neurotransmitter regulation, RPS7P2 has also been shown to play a role in the regulation of gene expression. Studies have shown that RPS7P2 can interact with various RNA molecules, including microRNA (miRNA) and long non-coding RNA (lncRNA). These interactions can alter the stability and translation efficiency of these RNA molecules, potentially leading to changes in gene expression.

The potential drug target status of RPS7P2 is due to its involvement in various cellular processes and its role in the regulation of gene expression. The protein is also known to be a potential therapeutic target in neurodegenerative diseases, as several studies have shown that inhibition of RPS7P2 can improve the survival and cognitive function of models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In conclusion, RPS7P2 is a well-studied RNA-protein interaction that plays a crucial role in regulating various cellular processes, including neurotransmitter release and gene expression. Its potential as a drug target makes it an attractive target for the development of new treatments for neurodegenerative diseases. Further research is needed to fully understand the mechanisms of RPS7P2's role in neural function and its potential as a therapeutic target.

Protein Name: Ribosomal Protein S7 Pseudogene 2

The "RPS7P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS7P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets